Federal regulators will soon allow over the counter sales of Narcan, the nasal spray version of the drug Naloxone, which treats opioid overdoses. Concerns have been raised about pricing for the drug. Laura Palombi, PharmD, MPH, PAT, AE-C, commented: “It’s not just about accessibility. It also sends a message — we’re trying to remove the stigma around the drug….”
